|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.38 DKK | +1.36% |
|
-0.98% | -6.44% |
| 03-23 | H. Lundbeck Price Target Down as AlphaValue/Baader Europe Expects Patent Expirations to Weigh on Growth | MT |
| 03-20 | H Lundbeck: Markets need more proof of growth promise |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Pharmaceuticals Wholesale
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.09B | |||||
| 106B | |||||
| 50.72B | |||||
| 21.93B | |||||
| 9.24B | |||||
| 8.42B |
- Stock Market
- Equities
- HLUN B Stock
- Charts H. Lundbeck A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition